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Abstract
Purpose In cancer of unknown primary (CUP), positron emission tomography/computed tomography (PET/CT) with the glu-
cose analog [18F]FDG represents the standard imaging approach for localization of the malignant primary. Frequently, however,
[18F]FDG PET/CT cannot precisely distinguish between small occult tumors and chronic inflammation, especially inWaldeyer’s
tonsillar ring. To improve the accuracy for detecting primary tumors in the Waldeyer’s tonsillar ring, the novel PET tracer
[68Ga]Ga-FAPI-4 for specific imaging of fibroblast activation protein (FAP) expression was used as a more specific target for
cancer imaging.
Methods Eight patients with suspicion of a malignant tumor in Waldeyer’s tonsillar ring or a CUP syndrome were examined.
PET/CT scans with [18F]-FDG and [68Ga]Ga-FAPI-4 were performed for pre-operative tumor localization. After surgical
resection, histopathological and immunohistochemical results were compared to PET/CT findings.
Results Histopathology revealed a palatine or lingual tonsil carcinoma in all patients. In case of lymph node metastases smaller than
7 mm in size, the [18F]FDG PET/CT detection rate of cervical lymph node metastases was higher than that of [68Ga]FAPI PET/CT,
while both tracers identified the primary tumors in all eight cases. The size of the primary and the lymph node metastases was directly
correlated to the respective FAP expression, as detected by immunohistochemistry. The mean SUVmax for the primary tumors was
21.29 ± 7.97 for 18F-FDG and 16.06 ± 6.29 for 68Ga-FAPI, respectively (p = 0.2). The mean SUVmax for the healthy contralateral
tonsils was 8.38 ± 2.45 for [18F]FDG and 3.55 ± 0.47 for [68Ga]FAPI (p < 0.001). The SUVmax ratio of [
68Ga]FAPI was significantly
different from [18F] FDG (p = 0.03). Mean TBRmax for the [
68Ga]Ga-FAPI-4 tracer was markedly higher in comparison to [18F]FDG
(10.90 vs. 4.11).
Conclusion Non-invasive imaging of FAP expression by [68Ga]FAPI PET/CT resulted in a better visual detection of the malig-
nant primary in CUP, as compared to [18F]FDG imaging. However, the detection rate of lymph node metastases was inferior,
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presumably due to low FAP expression in small metastases. Nevertheless, by offering a detection method for primary tumors
with the potential of lower false positive rates and thus avoiding biopsies, patients with CUP syndrome may benefit from
[68Ga]FAPI PET/CT imaging.
Keywords Waldeyer’s tonsillar ring . Cancer of unknown primary (CUP) . Positron emission tomography/computed tomography
(PET/CT)
Introduction
The incidence of head and neck squamous cell carcinoma
(HNSCC) is more than 600,000 new cases per year world-
wide, while almost half of the patients die from this disease
[1]. The progression of the disease as well as the individual
prognosis is influenced by several factors, including tumor
size and localization, extranodal tumor spread, presence of
distant metastases, and the degree of tumor differentiation
[2]. With a percentage of 2–9% HNSCC manifests itself in
clinical practice only through cervical lymph node metastases,
while no obvious evidence of a primary tumor is observed [3].
This subgroup is defined as cancer of unknown primary
(CUP), which requires a detailed medical history. Clinical
examination and pre-operative imaging are important to local-
ize the malignant primary. Using computed tomography (CT),
the detection rate of the primary tumor in CUP is approximate-
ly 16% or up to 41% combining information from CT and
magnetic resonance imaging [4]. Positron emission
tomography/computed tomography (PET/CT) with
fluorodeoxyglucose ([18F]FDG) has been established in
Germany as gold standard for primary pre-operative staging
in CUP [5]. The detection rate of the primary tumor was im-
proved to 86%, with a specificity of 69% by using [18F]FDG
PET/CT (FDG PET/CT) [6, 7].
In most patients with CUP, occult primary tumors are lo-
calized in the palatine tonsils and the base of the tongue [8].
However, tumors in the Waldeyer’s tonsillar ring are difficult
to distinguish from chronic inflammation in FDG PET/CT
scans. This leads to frequent false positive findings which
occur in up to 39% of cases [9]. Due to a lack of accuracy,
panendoscopy accompanied by multiple biopsies, bilateral
tonsillectomy, and superficial tongue base laser resection is
necessary [10]. However, these invasive procedures are asso-
ciated with postoperative risks, such as postoperative bleed-
ing. A higher specificity of diagnostic imaging would allow a
better identification rate of small oropharyngeal cancers
which—due to artifacts—are not detectable by FDG PET/
CT. In those cases, diagnostic tonsillectomy could be avoided.
Cancer-associated fibroblasts (CAFs) are located within
the tumor stroma of most epithelial tumors and belong to a
subpopulation of fibroblasts [11]. By secreting various cyto-
kines, chemokines and growth factors CAFs play an essential
role for the tumor microenvironment. Often the invasiveness
of the tumor invasion is promoted by the interaction between
CAFs and tumor cells, for instance in oral squamous cell car-
cinoma [12]. A hallmark of CAFs is the overexpression of
fibroblast activation protein (FAP) on their cell surface [13].
FAP corresponds to a type II transmembrane glycoprotein that
acts as a serine protease of the DiPeptidyl-peptidase family
(DPP) [11]. Expression of FAP was described in association
to diverse carcinomas, such as in breast and colorectal carci-
nomas, and in oropharyngeal cancer [11, 14, 15]. In its active
dimeric form, FAP acts as an exo- and endopeptidase,
influencing the proliferation, migration, and invasion of tumor
cells [15–18]. In contrast, FAP is absent in normal adult tis-
sues [19].
The radiolabeled FAP-targeted inhibitor [68Ga]Ga-FAPI-4
(FAPI) was developed as a tracer for PET/CT imaging [20].
The aim of this study was to improve the detection rate and
localization of suspected palatine and lingual tonsil carcino-
mas by non-invasive imaging. For this reason, we compared
this novel tracer with the standard [18F]FDG imaging.
Patients, materials, and methods
Patients
In the current retrospective study, we analyzed eight patients
who were treated for suspected carcinomas of the Waldeyer’s
tonsillar ring from November 2018 to January 2020. Initially,
the suspected diagnosis was an oropharyngeal cancer or rather
a CUP syndrome as differential diagnosis. All patients re-
ceived FDG PET/CT as pre-operative staging for tumor de-
tection. In order to distinguish tumor tissue more precisely
from inflammatory tissue, an additional FAPI PET/CT scan
was performed. The results were compared to a control group
(n = 15) that had no oral cancer (Table 1). [68Ga]Ga-FAPI-4
was offered on a compassionate use base and in compliance
with “37 ofDeclaration of Helsinki and the GermanMedicinal
Products Act, AMG” 13 2b. All patients were informed and
gave their written consent for pre-operative imaging.
Subsequently, a diagnostic panendoscopy was carried out
with biopsy of the suspected lesion. The TNM staging system
was applied according to the American Joint Committee on
Cancer (AJCC) classification of head and neck cancer. After
the histopathological analysis confirmed the primary tumor,
all patients received tumor resection and neck dissection of the
affected side. The immunohistochemical stainings for FAP in
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the resected tissues—in comparison to PET/CT imaging—
were approved by the Ethic Committee of the Medical
Faculty, University of Wuerzburg (no. 123/19).
Patient data
The mean patient age was 62 years (with a range of 58–72
years). In all cases, tumors were transoral resected and imme-
diately checked by an experienced pathologist with regard to
the resection margins. In case of a positive resection margin, a
further resection in combination with a neck dissection of the
tumor-affected side was performed. Subsequently, a detailed
analysis of the tumor with regard to grading, perineural infil-
tration, or HPV infection status was performed. The lymph
nodes, which were resected in the course of neck dissection,
were fixed in formalin. Subsequently, the presence of metas-
tases was analyzed by an experienced pathologist.
All patients showed a histopathological result of squamous
cell carcinoma. Seventy-five percent of which were positive
for p16/HPV (human papillomavirus)-positive (Table 2). One
patient (patient #4) had a p16-negative T3 tonsil carcinoma
and a simultaneous T1 hypopharyngeal carcinoma (Fig. 1).
The second carcinoma was removed by transoral laser micro-
surgery in the same surgical session. In two patients (patients
#2 and #3), an additional tracer uptake in the lung was detect-
ed by PET/CT during pre-operative staging. In patient #2,
histopathological examination revealed a primary lung carci-
noma as secondary malignancy. In patient #3, histopatholog-
ical work-up of the lung lesion also revealed a squamous cell
carcinoma, whereas the distinction between primary lung car-
cinoma and a metastatic lesion was impossible based on
histopathology. Six out of 8 patients (75%) received adjuvant
radiochemotherapy with a radiation dose of up to 66 Gy and 4
cycles of cisplatin.
At the last time point of clinical follow-up (March 2020),
six out of 8 patients (75%) were in complete remission. Only
patient #4 showed a progressive disease with new pulmonary
metastases during restaging with FDG PET/CT in May 2019,
which were not detected pre-operatively. Patient #6was lost to
follow-up.
Imaging and image analysis
All pre-operative PET/CT examinations were performed on a
Siemens Biograph mCT 64, (Siemens Healthineers, Erlangen,
Germany). The investigation was carried out after the initial
presentation of the patient at the Dept. of Otolaryngology,
Table 1 Control group (n = 15)
with a mean age of 60 years
(range 43–81; male 67%, female
33%)
Control group SUVmax right tonsil SUVmax left tonsil SUVmax right tonsil SUVmax left tonsil
1 10.37 9.36 2.65 2.63
2 3.12 3.59 1.47 1.42
3 8.48 7.63 2.82 3.81
4 3.45 3.85 3.03 3.41
5 7.44 5.64 3.67 3.27
6 6.32 5.95 2.51 2.12
7 3.91 3.91 3.67 3.52
8 6.34 6.05 3.57 2.79
9 6.44 6.51 3.63 3.66
10 5.95 7.96 4.32 4.24
11 5.79 6.93 3.84 3.08
12 7.13 4.93 2.67 2.88
13 12.32 9.69 4.01 3.97
14 7.31 4.91 2.61 1.89
15 5.06 5.62 2.65 2.36
Mean SUVmax 6.63 6.17 3.14 3.04
SUVmax ratio 1.18 1.11
Table 2 Patient characteristics (age, sex, and smoker) and the tumor
characteristics (localization and p16/HPV-status)
Patient Age Sex Smoker Tumor localization p16-
status
1 58 F No Palatine tonsil right side Positive
2 72 M Yes Palatine tonsil right side Negative
3 54 M No Lingual tonsil right side Positive
4 61 M Yes Palatine tonsil left side Negative
5 61 M No Palatine tonsil right side Positive
6 68 F Yes Palatine tonsil left side Positive
7 59 M Yes Palatine tonsil left side Positive
8 62 M Yes Palatine tonsil right side Positive
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Head and Neck Surgery of the University Hospital
Wuerzburg. Before imaging, the blood glucose levels were
tested in all patients and the metrics were below 165 mg/dl
in all patients. Sixty minutes after intravenous injection of
approximately 300 MBq 18F-FDG (average 292 ± 32 MBq),
imaging was performed. First, a full-body protocol with lifted
arms was performed, followed by a head and neck protocol
(i.e., arms in down-position). In the head and neck protocol,
the patients were imaged from the base of the skull to the
upper thoracic aperture with a 30-cm field of view and a 128
× 128 matrix. PET section thickness was 5 mm. All PET
images were reconstructed iteratively.
Within 4 to 7 days, FAPI PET/CT was performed in low
dose technique. One hundred fifty megabecquerels (average
145 MBq) of [68Ga]Ga-FAPI-4 were injected intravenously.
After a 60-min incubation time, the abovementioned full body
as well as the head and neck protocols were performed, as men-
tioned above. Data evaluation was carried out using the manu-
facturer’s software (syngo MI.PET/CT; Siemens Healthineers,
Erlangen, Germany). PET/CT image interpretation was based
on visual and semiquantitative analysis and evaluated by two
experienced readers. Visual identification of a malignant tumor
in Waldeyer’s tonsillar ring was obtained by the asymmetry of
high tracer uptake in one of both tonsils. Caused by inflamma-
tory changes, the tracer [18F]FDG (FDG) has a strong physio-
logical uptake in both tonsils (range SUVmax 2.1–11.4) [21].
The physiological SUVmax ratio for FDG is between 0.70
and 1.36 in palatine tonsils [22]. For semiquantitative analysis,
a SUVmax ratio between tonsils of ≥ 1.6 for 18F-FDG [21] and ≥
1.5 for FAPI—in comparison to the control group (Table 1)—
were defined as PET positive for malignancy. Only lymph
nodes with high focal uptake (SUVmax ≥ 4.0 for FDG;
SUVmax ≥ 3.0 for FAPI) were classified as suspicious for ma-
lignancy. Consequently, lower focal FDG and FAPI uptakewith
matching node-like structures at CT scans were considered as
abnormal, irrespective of lymph nodal size.
The tumor suspected area in the pharyngeal was derived
from the region with the highest tracer uptake in correlation to
the clinical data. For the further analysis of normal tissue and
tumor tissues, regions of interest (ROIs) were defined with a
fixed diameter of 10 mm. The maximum standardized uptake
value (SUVmax) was calculated within the ROI as the most
important comparative value of the two tracers using the man-
ufacturer’s algorithm. The SUVmax of the contralateral tonsil
was calculated in the same way by defining the location with
the most intensive tracer uptake. The background SUVmax
was calculated from the aorta descendens. The ratio of
SUVmax values (SUVmax ratio) has been defined at the quo-
tient of the SUVmax of primary tumor and the normal contra-
lateral tonsil. This value is a quantitative measure to express
the asymmetrical tracer uptake in carcinomas and normal ton-
sils. The tumor-to-background ratio (TBR) is defined as quo-
tient SUVmax of the tonsil carcinoma divided by the back-
ground SUVmean.
Immunohistochemistry
Immunohistochemistry for FAP was performed according to
standard immunohistochemical protocols on formalin-fixed
paraffin-embedded tissue slides using an antibody generated
Fig. 1 PET/CT scans with the FDG and FAPI tracer of patient with
palatine tonsil carcinoma and simultaneous hypopharyngeal carcinoma.
a, b, c, d, e Coronar and axial slices of a partial body scan of FDG PET/
CT from patient #4. All five sections show a strong tracer uptake in the
left palatine tonsil (red arrow), but also in the contralateral normal tonsil.
The ipsilateral neck lymph node metastasis with an intensive tracer
uptake is marked by a green arrow. As an incidental finding, a second
carcinoma of hypopharynx was detected (yellow arrow). f, g, h, i, j
Coronar and axial sections of a partial body scan of FAPI PET/CT from
the same patient. In FAPI PET-CT, the primary tumor (blue arrow), the
cervical lymph node metastasis (green arrow), and the hypopharynx
carcinoma (yellow arrow) show an intensive tracer uptake. The
contralateral normal tonsil shows a very poor tracer uptake
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against the fibroblast activation protein alpha (Abcam,
ab207178; dilution 1:250). The immunostaining was assessed
by a scoring system adopted from Henry et al. [23]. The stain-
ing of stromal cells adjacent to the carcinoma infiltrate was
assessed as 0 (absence of FAP immunostaining), 1+ (weak
staining in < 10% of the tumor stromal cells), 2+ (positive
FAP immunostaining in 10% to 50% of surrounding stromal
cells), and 3+ (moderate to strong FAP immunostaining in >
50% of surrounding stromal cells). Tumor-free lymph nodes
showing negative staining for FAP together with tumor-free
tonsils were used as negative control.
Statistical analysis
The statistical evaluation was performed using Microsoft
Excel (Version 16.17). For descriptive statistics, the
quantitative values were given as mean value ± standard de-
viation. Two-sample t tests were performed to compare FAPI
and FDG metric measurements. A p value of 0.05 indicated
statistical significance. A p value of 0.001 indicated highest
statistical significance.
Results
Imaging results of primary tumors
In this study, the established tracer FDG was compared to the
FAPI tracer with regard to tracer uptake in cancer of
Waldeyer’s tonsillar ring and correlated to the tumor size
and FAP expression.
Fig. 2 PET/CT scans with the FDG and FAPI tracer of patient with
palatine tonsil carcinoma. a, b, c Coronar and axial slices of a partial
body scan by FDG PET/CT in patient #2. An intensive tracer uptake
was detected in palatine tonsils of both sides. The red arrow marks the
carcinoma of the right side, the orange arrow marks two lymph node
metastases d, e, f Coronar and axial slices of a partial body scan by
FAPI PET/CT from the same patient. Due to the intensive tracer uptake
of FAPI (blue arrow), in contrast to the FDG PET/CT, the right palatine
tonsil can be clearly identified as carcinoma. The left palatine tonsil
shows a very low tracer uptake. Only one of two lymph node
metastasis were seen on FAPI PET/CT (orange arrow)
Table 3 SUVmax/SUVmax ratio
measurement of palatine and
lingual tonsils. SUVmax mean and
SUVmax ratio mean. The
SUVmax mean significantly
different between primary tumor
and contralateral healthy tonsil in
FDG PET/CT (**p = 0.003) and
FAPI PET/CT (***p = 0.001).
Also the SUVmax ratio of FAPI
tracer distinguishes significantly
from SUVmax ratio of FDG tracer
(*p = 0.03)
Primary tumor Contralateral tonsil
FDG group (n = 8)
SUVmax mean 21.29** 8.38
Standard deviation 7.97 2.45
Range 10.35–34.1 5.8–13.2
SUVmax ratio mean 2.68
Standard deviation 1.27
Range 1.56–5.59
FAPI group (n = 8)
SUVmax mean 16.06*** 3.55
Standarddeviation 6.29 0.47
Range 6.6–28.2 2.9–4.1
SUVmax ratio mean 4.47*
Standard deviation 1.55
Range 2.13–6.88
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All primary tumors were detected by both tracers while FDG
showed higher uptake in all cases. Compared to contralateral
normal tonsils the mean SUVmax of the tumor tissue was sig-
nificantly higher in FDG imaging (p = 0.003) and even more
significant for FAPI PET/CT (p = 0.001; Fig. 2). In addition, all
normal tissues of the Waldeyer’s tonsillar ring showed a very
low tracer uptake in FAPI PET/CT scans (Table 3). The uptake
of FAPI in the normal tonsils was significantly lower than that
of FDG (p < 0.001) (Table 4 and Fig. 3). The mean SUVmax of
the control group for the right healthy tonsil was 6.6 for FDG
and 3.2 for FAPI, as well as 6.2 (FDG) and 3.0 (68FAPI) for the
left healthy tonsil. The mean SUVmax values of both tracers in
the tonsil carcinomas was markedly higher than surrounding
tissue with 21.3 ± 10.0 (FDG) and 15.9 ± 6.3 (FAPI). When
comparing mean SUVmax for both tracers of the contralateral
healthy tonsil, a significant difference of 8.2 ± 2.7 for FDG and
3.4 ± 0.58 for FAPI was observed. Consequently, the SUVmax
ratio of FDG was only 2.68 (range 1.56–5.59) and 4.10 (range
2.13–6.88) in case of FAPI. Moreover, FDG TBRmax mean
was less than a half with 4.11 (range 2.5–7.1) compared to
FAPI with a value of 10.89 (range 6.3–27.5) (Table 4).
Imaging results of lymph node metastases
All patients received a neck dissection as part of their therapy. A
total of 173 lymph nodes were dissected and histopathologically
analyzed. The results of the analyses were compared to the PET/
CT imaging findings. A total of 17 lymph node metastases could
be confirmed histopathologically (Table 5). Histopathological
results were compared to the findings at the FDG PET/CT scan.
Fourteen out of 17 lymph node metastases showed an intensive
pre-operative uptake of FDG. In contrast, only 8 lymph node
metastases showed an intensive uptake in FAPI scans.
Furthermore, histopathological results indicated that 156 out of
173 resected lymph nodes were tumor-free, and 3 lymph nodes
described as hypermetabolic upon FDG PET/CT imaging were
false positive. In contrast, none of the lymph nodes showed a
false positive result by FAPI PET/CT imaging, as detected upon
operation. Table 5 compiled for each patient the number and size
of histopathological positive and PET positive cervical lymph
nodes and the FAP expression.
Imaging results of secondary primaries
In two patients, concomitant secondary malignancies in the
lung were detected. Both tracers detected a secondary pri-
mary of the lung in patient #2 (histological confirmed
squamous cell carcinoma pT1b; 12 mm × 13 mm; FDG:
SUVmax 12.83; FAPI: SUVmax 6.26). In patient #3, it was
impossible to distinguish between a primary lung carcino-
ma or a metastasis. Interestingly, only FDG showed an
uptake in this 8-mm malignancy with a SUVmax of 3.91
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Correlation of imaging results with
immunohistochemistry
With the immunohistochemical staining with the antibody,
which is specific for the FAP alpha protein, all primary tumors
and all lymph node metastasis except one were positive for
FAP alpha. The largest primary tumors (6 of 8) showed a
score of 3+ immunostaining for FAP, and one T1 and a small
T2 primary tumor were scored 2+. In lymph node metastases
of the size between 4 and 6 mm, there was only a weak FAP
expression (score 1+) without FAPI uptake. The score 2+ had
6- to 11-mm large lymph node metastases which were detect-
ed by FAPI PET/CT. With a size of 12 mm, all lymph node
metastases (score 3+) were detected by the FAPI tracer. Only
one lymph node metastasis had a score of 3+ with the size of 7
mm. The lymph node metastases (11 mm size) with no FAP
expression (score 0) remained undetected by both tracers.
Figure 4 gives an example of the FAP alpha protein expres-
sion by immunohistochemistry in the detected primary tumor
and a lymph node metastasis of patient #4. The exact FAP
expression for each lymph node metastases are shown in
Table 5.
Discussion
Initial staging is a fundamental element in diagnosis of head
and neck squamous cell carcinoma (HNSCC) and has major
impact on tumor therapy [24]. The most common location of
the occult primary tumors from clinical CUP syndrome are the
Table 5 Resected primary tumor and cervical lymph nodemetastases in
correlation with PET/CT scans and immunostaining. TNM-status of the
tumor, HPV (+/-), amount of lymph node metastases, the lymph node
metastases subdivision in FDG positive and FAPI positive lymph nodes,
FAP expression for each lymph node metastases and primary tumor,
primary tumor size
Patient TNM HPV (+/-) Lymph node
metastases size (mm)
FAPI/FDG (+/-) Immunostaining (0–3) Primary tumor
size (mm)




2 T2N3bM0 - 7 -/+ 3+ 3+ 35 × 13
7 +/+ 2+
3 T3N1Mx + 62 +/+ 3+ 3+ 40 × 9
4 T3N3bM0 - 4 -/+ 1+ 3+ 47 × 8
11 +/+ 2+
12 +/+ 3+
5 T1N1M0 + 27 +/+ 3+ 2+ 11 × 8
6 T2N2bM0 + 32 +/+ 3+ 2+ 22 × 8
6 -/- 1+
11 -/- 0
7 T2N1M0 + 50 +/+ 3+ 2+ 22 × 15
8 T3N1M0 + 4 -/+ 1+ 3+ 41 × 9
9 +/+ 3+
Fig. 3 Compilation of FDG and
FAPI tracer uptake in primary
tumor and contralateral healthy
tonsils. In contrast to FDG tracer,
the contralateral healthy tonsils
showed a very low FAPI tracer
uptake (***p < 0.001)
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tonsils and the base of the tongue [25]. In comparison to con-
ventional imaging, such as CT or MRI, FDG PET offers a
higher sensitivity and specificity for tumor detection [26].
After phosphorylation of FDG, tumor cells with increased
anaerobic glycolysis are predominantly labeled by the intra-
cellular accumulation of FDG tracer (metabolic trapping) [27].
However, the specificity of FDG is limited and frequently
leads to false positive results, in particular due to inflammato-
ry tissues [25, 28]. In those cases, panendoscopy including
bilateral tonsillectomy and biopsies of tongue base and naso-
pharynx are part of the procedure to detect primary tumors.
But the risk of a secondary bleeding after tonsillectomy can
occur in up to 5% of treated patients and can have fatal con-
sequences for the patients [29].
In contrast to the metabolism targeted tracer FDG, FAPI
reacts specifically with the surface protein FAP on CAFs
which can be found in tumor stroma of many squamous cell
carcinomas [11]. In this study, both tracers (FDG and FAPI)
were used for the detection of carcinomas in Waldeyer’s ton-
sillar ring. Asymmetrical uptake of both radiotracers was
found in all patients with preference in the tumor affected side
(FDG mean SUVmax 21.29; FAPI mean SUVmax 16.06). In
addition, the SUVmax of the non-malignant contralateral tonsil
was significantly lower for FAPI (3.55 ± 0.47) compared to
FDG PET/CT imaging (8.38 ± 2.45) (p < 0.001). The corre-
sponding SUVmax ratio for the FAPI tracer was higher in
almost all patients and differed significantly from the FDG
tracer. The distinct differences in the SUVmax ratio between
both tracers is based mainly on the very low uptake of FAPI in
the contralateral healthy tonsil in all patients, compared to the
tumor affected side (p = 0.001). In addition, the mean TBRmax
of the FAPI tracer was much higher in comparison to the FDG
tracer (10.90 vs. 4.11). Due to the higher mean values of
TBRmax and SUVmax, it is much easier to visually detect tu-
mor tissue and to separate it from inflammatory changes. All
primary tumors showed a correlation of size and intensity of
FAP immunostaining. One T1 and one small T2 primary tu-
mor showed a moderate FAP expression (score 2+), the larger
tumors (T2 and T3) had a high FAP expression of surrounding
stromal cells (score 3+). Hence, false positive results in tonsils
and inflammatory tissues could be avoided. This benefit of
FAPI PET/CT imaging may render biopsies in nasopharynx
unnecessary for CUP patients as well as bilateral tonsillecto-
my unnecessary for CUP patients. Therefore, tracer uptake in
the primary tumor could easily be differentiated from the
physiological uptake of surrounding tissue by FAPI PET/CT
imaging. Consequently, small tumors of T1 stage could be
detected more effectively by FAPI PET/CT imaging, and false
negative results might be reduced.
Apart from the detection of the primary tumor which is
essential for the planning of resective surgery, imaging mo-
dalities are a key element for the diagnosis of cervical lymph
node metastases and distant metastases. For the detection of
cervical lymph node metastases, FDG PET showed a higher
sensitivity than CT. Our study confirmed previous findings by
Yamazaki et al. [30]. In this study, it was reported that lymph
node metastases below 5 mm are usually not recognized by
FDG PET. With a lymph node metastases size of 5 to 9 mm,
the detection rate was 45%, and it rose to almost 100% by a
lymph node metastases size more than 10 mm [27]. In our
study, mainly HPV-positive carcinomas of palatine and lin-
gual tonsil with cervical lymph node metastases (75%) were
involved. By FAPI PET/CT imaging, the detection rate of
cervical lymph node metastases was independent from HPV
association. The detection rate of lymph node metastases was
47% in FAPI PET/CT (vs. 82% in FDG PET/CT). One reason
could be a reorganization process of the tumor microenviron-
ment, which is reported to be induced by HPV-positive epi-
thelia. These structural changes include thinning of the basal
membrane, apparent degradation and disruption of the
Fig. 4 Immunohistochemistry of resected tissue from patient #4. FAP
alpha immunohistochemistry from patient #4 (with positive staining of
stromal cells adjacent to the carcinoma infiltrate of the primary tumor (a
length of scale bar 500 μm) and a b lymph node metastasis. cNo staining
for FAP alpha was observed in a tumor free lymph node
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collagen fibril network, and additional disintegration of the
extracellular matrix [31]. Thus, the lower sensitivity for small
metastases could be explained by a delayed conversion of
normal fibroblasts towards FAP overexpressing CAFs [32].
This would result in a lower FAP occurrence in cervical
lymph node metastases especially in early stages of metasta-
sis, which was also apparent in immunohistochemistry.
The FAP expression of lymph node metastases also ap-
pears to correlate with the size of the lesion. Lymph nodes
up to 7 mm in size showed only a weak FAP expression in
less than 10% of the surrounding tumor-associated stromal
cells (stain score 1+). This resulted in a negative FAPI scan.
In contrast, all lymph node metastases between 7 and 62 mm
in size were detected pre-operatively by using FAPI and FDG
(stain score 2+/3+). Probably due to its cystic morphology, a
sole lymph node metastasis with a size of 11 mm showed a
negative FAP immunostaining and no tracer uptake in imag-
ing. The timespan of tumor development of cervical lymph
node metastases is certainly an important parameter for the
transformation of normal fibroblasts into CAFs, and the over-
expression of FAP as a target for the FAPI tracer.
There are several limitations of our study. These include
the very small number of patients and the unbalanced distri-
bution of HPV-positive and -negative tumors. Furthermore,
due to the lack of follow-up, analysis of the long-term prog-
nosis analysis regarding disease-free and overall survival is
currently not feasible. In the future, a larger patient cohort will
be necessary to study FAPI PET/CT in HNSCC. Especially
immunohistochemical studies of HPV-positive and -negative
tumors are necessary to further investigate the interaction be-
tween primary tumor/cervical lymph node metastases and
CAFs as well as FAP.
In conclusion, the differentiation between primary tumor
and surrounding or contralateral normal tonsillar tissue is im-
proved by FAPI as compared to the standard PET radiotracer
FDG. Therefore, small occult cancers in the Waldeyer’s ton-
sillar ring may be detected by FAPI PET/CT with higher pre-
cision. Especially in patients with suspected CUP syndrome,
FAPI PET/CT might reveal small primary tumors in the ton-
sils without the requirement of diagnostic bilateral tonsillecto-
my. A more precise therapy planning by means of improved
PET/CT imaging, as well as the reduction of postoperative
complications may lead to a better outcome of patients.
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